n-((2-dimethylamino)ethyl)-9-aminoacridine-4-carboxamide has been researched along with Experimental Leukemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atwell, GJ; Baguley, BC; Denny, WA; Palmer, BD; Rewcastle, GW | 1 |
Atwell, GJ; Baguley, BC; Denny, WA; Rewcastle, GW | 2 |
3 other study(ies) available for n-((2-dimethylamino)ethyl)-9-aminoacridine-4-carboxamide and Experimental Leukemia
Article | Year |
---|---|
Potential antitumor agents. 54. Chromophore requirements for in vivo antitumor activity among the general class of linear tricyclic carboxamides.
Topics: Aminacrine; Animals; Antineoplastic Agents; Benzofurans; Chemical Phenomena; Chemistry, Physical; Dioxins; DNA; Heterocyclic Compounds; Hydrogen-Ion Concentration; Intercalating Agents; Leukemia, Experimental; Structure-Activity Relationship; Tyramine | 1988 |
Potential antitumor agents. 49. 5-substituted derivatives of N-[2-(dimethylamino)ethyl]-9-aminoacridine-4-carboxamide with in vivo solid-tumor activity.
Topics: Aminoacridines; Animals; Antineoplastic Agents; Carcinoma; Cell Line; Chemical Phenomena; Chemistry; Colonic Neoplasms; DNA; Intercalating Agents; Leukemia, Experimental; Lung Neoplasms; Mice; Rats; Structure-Activity Relationship | 1987 |
Potential antitumor agents. 50. In vivo solid-tumor activity of derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
Topics: Aminoacridines; Animals; Antineoplastic Agents; Carcinoma; Chemical Phenomena; Chemistry; DNA; Intercalating Agents; Leukemia P388; Leukemia, Experimental; Lung Neoplasms; Mice; Structure-Activity Relationship | 1987 |